tiprankstipranks
CIMG (CIMG)
OTHER OTC:CIMG
Want to see CIMG full AI Analyst Report?

CIMG (CIMG) AI Stock Analysis

243 Followers

Top Page

CIMG

CIMG

(OTC:CIMG)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 5.2)
Rating:39Underperform
Price Target:
<$0.01
▼(-99.26% Downside)
Action:Reiterated
Date:06/23/26
The score is held down primarily by very weak financial performance—extreme net losses and substantial ongoing cash burn—despite strong recent revenue growth and low reported leverage. Technical indicators also reflect a pronounced downtrend (price far below major moving averages) with oversold momentum. Valuation provides little support given a negative P/E and no dividend yield.
Positive Factors
Revenue Growth & Commercialization
Sharp, sustained top-line growth and early-stage commercialization indicate the company is scaling product sales and entering new revenue channels. Over the next 2–6 months this provides a larger base for operational leverage and validates go-to-market execution if growth continues and customer uptake holds.
Negative Factors
Severe Cash Burn
Persistent, large negative operating and free cash flows consume liquidity and force reliance on external financing or asset sales. Over 2–6 months this elevates execution risk, may require dilutive capital raises, and constrains R&D, capex and commercial investments needed to realize strategic opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth & Commercialization
Sharp, sustained top-line growth and early-stage commercialization indicate the company is scaling product sales and entering new revenue channels. Over the next 2–6 months this provides a larger base for operational leverage and validates go-to-market execution if growth continues and customer uptake holds.
Read all positive factors

CIMG (CIMG) vs. SPDR S&P 500 ETF (SPY)

CIMG Business Overview & Revenue Model

Company Description
NuZee, Inc., together with its subsidiaries, manufactures, packs, and sells single-serve pour-over coffee and tea bag-style coffee for coffee roasters and food service companies in North America, South Korea, Singapore, Hong Kong, Mainland China, ...

CIMG Financial Statement Overview

Summary
Despite sharp TTM revenue growth (+153.1%), performance is dominated by severe unprofitability (gross margin ~0.7%, EBIT margin ~-15.0%, net margin ~-87.6%) and heavy cash burn (TTM operating cash flow and free cash flow about -$32.8M). The balance sheet is currently lightly levered (debt-to-equity ~0.01), but very weak returns (ROE ~-72.7%) and past negative equity indicate elevated execution and funding risk.
Income Statement
14
Very Negative
Balance Sheet
56
Neutral
Cash Flow
9
Very Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

CIMG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.22
Price Trends
50DMA
0.04
Negative
100DMA
0.26
Negative
200DMA
1.96
Negative
Market Momentum
MACD
-0.01
Negative
RSI
22.53
Positive
STOCH
19.94
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIMG, the sentiment is Negative. The current price of 1.22 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.04, and below the 200-day MA of 1.96, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 22.53 is Positive, neither overbought nor oversold. The STOCH value of 19.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIMG.

CIMG Risk Analysis

CIMG disclosed 3 risk factors in its most recent earnings report. CIMG reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CIMG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
$11.41M7.653795.06%-8.74%-33.18%
44
Neutral
$27.14M-26.5771.25%
42
Neutral
$10.92M-0.67-28.46%3788.45%96.39%
39
Underperform
$941.72K-0.13-72.69%4214.95%94.52%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CIMG
CIMG
0.01
-5.57
-99.82%
BTOG
Bit Origin
1.25
-8.10
-86.64%
PAVS
Paranovus Entertainment Technology
7.43
-111,112.56
-99.99%
COOT
Australian Oilseeds Holdings
0.58
-0.17
-22.53%
WYHG
Wing Yip Food Holdings Group Limited Sponsored ADR
4.06
-1.50
-26.98%

CIMG Corporate Events

Business Operations and Strategy
CIMG Expands into Large-Scale AI Computing Services
Positive
Jun 22, 2026
On June 22, 2026, CIMG Inc. announced that its wholly owned subsidiary Zhongyan Shangyue Technology signed a framework contract with Zhongshishun Technology (Beijing) to act as general contractor for the construction and operation of a computing p...
Business Operations and StrategyRegulatory Filings and Compliance
CIMG Expands Authorized Share Capital Through Charter Amendment
Neutral
Jun 4, 2026
On April 14, 2026, CIMG Inc.&#8217;s board of directors and holders of a majority of its outstanding voting power approved an increase in the company&#8217;s authorized common stock, expanding the potential share count from 2,000,000,000 to 5,000,...
Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresM&A TransactionsPrivate Placements and FinancingProduct-Related AnnouncementsRegulatory Filings and Compliance
CIMG Reports Strong Growth and Expands Bitcoin Reserves
Positive
Mar 25, 2026
CIMG Inc., a Hong Kong-based digital health and sales development group, is pursuing a dual-track strategy in health consumer goods and computing power technology products across Asia, underpinned by AI-driven marketing and a cryptocurrency-focuse...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 23, 2026